SCHEMBL16357564

SCHEMBL16357564

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4cc5c(ccn5-c5ccccc5)cc43)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ PLA2G4A P47712 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ TERT O14746 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ CYP19A1 P11511 1/20 0.30
▸ BIRC5 O15392 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ PARP1 P09874 1/20 0.30
▸ DHODH Q02127 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15857509 0.96 KDM4E (0.38) KDM4EL3MBTL1ATM
SCHEMBL15802348 0.96 KDM4E (0.33) KDM4EL3MBTL1ATMPLA2G4ATSHR
SCHEMBL15801462 0.96 KDM4E (0.33) KDM4EL3MBTL1ATMPLA2G4ATSHR
SCHEMBL16357440 0.95 KDM4E (0.35) KDM4EL3MBTL1ATMPLA2G4AMEN1
SCHEMBL15857519 0.95 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4AKMT2A
SCHEMBL15857192 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4AKMT2A
SCHEMBL15857195 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4AKMT2A
SCHEMBL15857394 0.92 KDM4E (0.33) KDM4EL3MBTL1ATM
SCHEMBL20426273 0.91 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL15632025 0.91 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU KDM4E 1494/4885L3MBTL1 464/4885ATM 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback